What does DR. SCHERPENBERG do?

DR. SCHERPENBERG is a general practice in Bilzen-Hoeselt. Private Limited, started on 26 January 2007, 2 establishments.

What is the address of DR. SCHERPENBERG?

The registered office of DR. SCHERPENBERG is located at Leterweg 63, 3740 Bilzen-Hoeselt.

Is DR. SCHERPENBERG still active?

Yes. According to the CBE (17 September 2026) DR. SCHERPENBERG is active, legal situation “Normale toestand”, started on 26 January 2007.

Is DR. SCHERPENBERG registered on Peppol?

Yes, DR. SCHERPENBERG is registered on the Peppol network with ID 0208:0887033029.

What is the enterprise number of DR. SCHERPENBERG?

The enterprise number of DR. SCHERPENBERG is BE0887033029.

When was DR. SCHERPENBERG founded?

DR. SCHERPENBERG was founded on 26 January 2007.

Who are the directors of DR. SCHERPENBERG?

According to the 2025 annual accounts, the directors of DR. SCHERPENBERG are: RUDI JOZEF SCHERPENBERG.

Is DR. SCHERPENBERG a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 January 2007; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did DR. SCHERPENBERG make in 2025?

DR. SCHERPENBERG posted a profit after taxes of € 54,281 in financial year 2025.

What is the revenue of DR. SCHERPENBERG?

As a small company, DR. SCHERPENBERG is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 87,517.

DR. SCHERPENBERG (Private Limited) - Bilzen-Hoeselt

Dossier DR. SCHERPENBERG, printed on 17 September 2026 from databakkes.be/en/0887033029/dr-scherpenberg. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. SCHERPENBERG from Bilzen-Hoeselt, company number BE0887033029, closed financial year 2025 with a result of € 54,281 after tax. For that financial year DR. SCHERPENBERG recorded a gross margin of € 87,517 and equity of € 241,424. Compared with financial year 2024, the result moved from € 35,854 to € 54,281. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on December 4, 2025.

What it is worth Healthy

€ 241,424

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 54,281

▲ 51% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 193,332

▲ 44% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 55,230 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 10,815

▼ 25% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 6,686

▲ 9% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 5,055

▲ 90% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,315

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 55,308 Gross margin 2022: € 55,308 First fiscal year in the series	€ 50,537 Gross margin 2023: € 50,537 ▼ 9% vs 2022 (€ 55,308) Unfavourable step	€ 58,947 Gross margin 2024: € 58,947 ▲ 17% vs 2023 (€ 50,537) Favourable step	€ 87,517 Gross margin 2025: € 87,517 ▲ 48% vs 2024 (€ 58,947) Favourable step	▲ 48%
Profit after taxes	€ 33,241 Profit after taxes 2022: € 33,241 First fiscal year in the series	€ 32,101 Profit after taxes 2023: € 32,101 ▼ 3% vs 2022 (€ 33,241) Unfavourable step	€ 35,854 Profit after taxes 2024: € 35,854 ▲ 12% vs 2023 (€ 32,101) Favourable step	€ 54,281 Profit after taxes 2025: € 54,281 ▲ 51% vs 2024 (€ 35,854) Favourable step	▲ 51%
Equity	€ 212,337 Equity 2022: € 212,337 First fiscal year in the series	€ 206,518 Equity 2023: € 206,518 ▼ 3% vs 2022 (€ 212,337) Unfavourable step	€ 242,372 Equity 2024: € 242,372 ▲ 17% vs 2023 (€ 206,518) Favourable step	€ 241,424 Equity 2025: € 241,424 Unchanged (€ 242,372) Unfavourable step
Total debts	€ 8,279 Total debts 2022: € 8,279 First fiscal year in the series	€ 15,296 Total debts 2023: € 15,296 ▲ 85% vs 2022 (€ 8,279) Unfavourable step	€ 12,987 Total debts 2024: € 12,987 ▼ 15% vs 2023 (€ 15,296) Favourable step	€ 70,092 Total debts 2025: € 70,092 ▲ € 57,104 vs 2024 (€ 12,987) Unfavourable step	▲ € 57,104
Cash	€ 186,027 Cash 2022: € 186,027 First fiscal year in the series	€ 113,167 Cash 2023: € 113,167 ▼ 39% vs 2022 (€ 186,027) Unfavourable step	€ 134,484 Cash 2024: € 134,484 ▲ 19% vs 2023 (€ 113,167) Favourable step	€ 193,332 Cash 2025: € 193,332 ▲ 44% vs 2024 (€ 134,484) Favourable step	▲ 44%
Retained profit	€ 193,737 Retained profit 2022: € 193,737 First fiscal year in the series	€ 187,918 Retained profit 2023: € 187,918 ▼ 3% vs 2022 (€ 193,737) Unfavourable step	€ 223,772 Retained profit 2024: € 223,772 ▲ 19% vs 2023 (€ 187,918) Favourable step	€ 222,824 Retained profit 2025: € 222,824 Unchanged (€ 223,772) Unfavourable step
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 37,920 Dividend 2023: € 37,920 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 37,920) Unchanged	€ 55,230 Dividend 2025: € 55,230 Unchanged (€ 0) Unchanged
Bank debt	€ 3,903 Bank debt 2022: € 3,903 First fiscal year in the series	€ 5,066 Bank debt 2023: € 5,066 ▲ 30% vs 2022 (€ 3,903) Unfavourable step	€ 6,156 Bank debt 2024: € 6,156 ▲ 22% vs 2023 (€ 5,066) Unfavourable step	€ 6,686 Bank debt 2025: € 6,686 ▲ 9% vs 2024 (€ 6,156) Unfavourable step	▲ 9%
Balance sheet total	€ 220,616 Balance sheet total 2022: € 220,616 First fiscal year in the series	€ 221,814 Balance sheet total 2023: € 221,814 ▲ 1% vs 2022 (€ 220,616) Unchanged	€ 255,359 Balance sheet total 2024: € 255,359 ▲ 15% vs 2023 (€ 221,814) Unchanged	€ 311,515 Balance sheet total 2025: € 311,515 ▲ 22% vs 2024 (€ 255,359) Unchanged	▲ 22%

Key figures of DR. SCHERPENBERG, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to DR. SCHERPENBERG?

What happened at DR. SCHERPENBERG in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Dec 4, 2025 New annual accounts for financial year 2025: profit of € 54,281 (▲ 51% vs 2024). Source: NBB ↗
Nov 1, 2014 New establishment in Bilzen-Hoeselt. KBO
Feb 6, 2007 New establishment in Bilzen-Hoeselt. KBO
2007 RUDI JOZEF SCHERPENBERG became a director. NBB
Jan 26, 2007 Start of the company according to the CBE. KBO

In short

From € 33,241 profit in 2022 to € 54,281 profit in 2025.

Paid € 67,518 in corporate taxes since 2022.

Best year ever: 2025, with € 54,281 profit.

Paid out € 93,150 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. SCHERPENBERG? We notify you, reason included.

Follow DR. SCHERPENBERG

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

RUDI JOZEF SCHERPENBERG

DR. SCHERPENBERG

Behind DR. SCHERPENBERG is RUDI JOZEF SCHERPENBERG.

See the full network in the app

Directors

According to the 2025 annual accounts

RUDI JOZEF SCHERPENBERG

Director

since 2007

Establishments

Establishment units

Physical locations of this company

Registered office

Leterweg 63

3740 Bilzen-Hoeselt

2.235.515.547

Rode Kruislaan 138

3740 Bilzen-Hoeselt

Active since 1 November 2014

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0887.033.029

VAT number

BE 0887.033.029

Registered office

Leterweg 63, 3740 Bilzen-Hoeselt

Names & denominations

DR. SCHERPENBERG

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

26 January 2007

Peppol

Active · Active since 17 Nov 2025

Activities · NACE

Activiteiten van huisartspraktijken

Overige persoonlijke diensten

View on CBE Public ↗ Annual accounts (NBB) ↗

DR. SCHERPENBERG

Financials

What happened to DR. SCHERPENBERG?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions